By July 27, 2021 - 11:17 pm MORGANTOWN, W.Va. — With the closure process of the Viatris facility in Morgantown slated to begin Saturday, a leader with West Virginia University’s Bureau of Business and Economic Research says the planned action shows the importance of economic diversity. Viatris, a company formed following the merger of Mylan Pharmaceuticals and Pfizer subsidiary Upjohn, will close the plant as part of an international business plan. Around 1,400 workers at the Morgantown facility will lose their jobs as a result of the action. John Deskins (File) John Deskins, the director of the Bureau of Business and Economic Research, said West Virginia has struggled with low labor participation rates and an image issue.